Study: Potential New Treatment Identified for Liver Disease
June 26, 2023
Researchers with UC San Diego School of Medicine identified a potential new drug that improved liver fibrosis in patients with NASH by 27%.
Your search for “Clinical Trials” returned 730 results
Rock Tour “Text2Give” Supports Immunotherapy at UC San Diego Health
April 19, 2017
…survive tongue cancer but after participating in an immunotherapy clinical trial at Moores Cancer Center at UC San Diego Health, he was declared cancer-free in July 2016. To give back, Rockett is now asking concert-goers to join him in supporting immunotherapy at Moores Cancer Center.
UC San Diego Health Expands Leading-Edge Cancer Care in Hillcrest
February 5, 2019
To make it easier for patients to receive world-class cancer care, UC San Diego Health has added a new multidisciplinary cancer clinic in Hillcrest and expanded its infusion center for both oncology patients and others in need of infusion services.
Home-Based Tools Can Help Assess Dementia Risk and Progression
March 28, 2019
Researchers at University of California San Diego School of Medicine, with colleagues elsewhere, report on a novel four-year, randomized clinical trial evaluating different home-based methods to assess cognitive function and decline in participants over the age of 75.
UC San Diego Health System Expands, Acquires Nevada Cancer Institute
January 23, 2012
…care to patients through expert diagnosis, novel treatments and clinical trials.
CIRM Grant to Fund Proposed Stem Cell Trials for ALS
March 17, 2016
The Independent Citizens Oversight Committee of the California Institute for Regenerative Medicine approved yesterday a $6.3 million grant to a research team from the University of California, San Diego School of Medicine and University of California, Davis to pursue a novel human embryonic stem cell-based therapy to rescue and restore…
Phase I Trial Finds Experimental Drug Safe in Treating Chronic Lymphocytic Leukemia
June 1, 2018
…a first-in-human phase I clinical trial, researchers at University of California San Diego School of Medicine have found that treatment with cirmtuzumab, an experimental monoclonal antibody-based drug, measurably inhibited the “stemness” of chronic lymphocytic leukemia cancer (CLL) cells — their ability to self-renew and resist terminal differentiation and senescence.
UC San Diego Health Named Dementia Research Center of Excellence
April 3, 2018
The Lewy Body Dementia Association (LBDA), announced today that UC San Diego Health has been named a LBDA Research Centers of Excellence (RCOE), a partnership of 24 pre-eminent academic medical research centers across the United States. LBDA is a leading advocacy group dedicated to raising awareness and advancing research and…
CAR Trials Drive Leukemia and Lymphoma Treatment in New Direction
February 23, 2016
…UC San Diego Moores Cancer Center have launched three clinical trials to test the safety and efficacy of a novel cellular-immunotherapy that uses modified T cells – one of the immune system’s primary weapons – to treat three different types of blood cancer that often defy existing therapies.
Vulnerability Identified for Subtypes of Glioblastoma
November 30, 2017
Glioblastoma, the most common and aggressive form of brain cancer, typically fails to respond to treatment or rapidly becomes drug resistant. In a paper published online in the journal Cancer Cell on November 30, University of California San Diego School of Medicine researchers identified a strategy that pinpoints a genetically…
